Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ecovyst Inc.ECVT · Entity 4897 | Director | February 03, 2026 | February 05, 2026 |
| Frontdoor, Inc.FTDR · Entity 3853 | Director | May 13, 2026 | May 15, 2026 |
| HF Sinclair CorpDINO · Entity 3289 | Director | November 12, 2025 | November 13, 2025 |
| HollyFrontier CorpHFC · Entity 132880 | Director | November 10, 2021 | November 10, 2021 |
| WILLIS TOWERS WATSON PLCWTW · Entity 3139 | Director | May 11, 2022 | May 13, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ecovyst Inc.
Report date February 03, 2026 · Filed February 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 102,805 |
Reported balance
After 2026-02-03 transaction · row 1
1 source rowRow 1 · 2026-02-03 · Grant · Acquired 19,399 · Balance 102,805 |
Frontdoor, Inc.
Report date May 13, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,349 |
Reported balance
After 2026-05-13 transaction · row 1
1 source rowRow 1 · 2026-05-13 · Grant · Acquired 2,836 · Balance 36,349 F1: Shares issued pursuant to the Frontdoor, Inc. 2018 Omnibus Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares issued pursuant to the Frontdoor, Inc. 2018 Omnibus Incentive Plan.
HF Sinclair Corp
Report date November 12, 2025 · Filed November 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,951 |
Reported balance
After 2025-11-12 transaction · row 1
1 source rowRow 1 · 2025-11-12 · Grant · Acquired 2,943 · Balance 30,951 F1: Restricted stock units granted under the HF Sinclair Corporation Amended and Restated 2020 Long Term Incentive Plan. The restricted stock units are subject to restrictions that will lapse on December 1, 2026 (or on the first business day thereafter if such date falls on a weekend), provided the reporting person has served on the board of directors of the Issuer from the grant date until such vesting date. Unless settlement is deferred pursuant to the Issuer's deferred compensation arrangement for directors, the vested restricted stock units will be paid within 30 days following the vesting date in the form of the Issuer's common stock equal to the number of vested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units granted under the HF Sinclair Corporation Amended and Restated 2020 Long Term Incentive Plan. The restricted stock units are subject to restrictions that will lapse on December 1, 2026 (or on the first business day thereafter if such date falls on a weekend), provided the reporting person has served on the board of directors of the Issuer from the grant date until such vesting date. Unless settlement is deferred pursuant to the Issuer's deferred compensation arrangement for directors, the vested restricted stock units will be paid within 30 days following the vesting date in the form of the Issuer's common stock equal to the number of vested restricted stock units.
HollyFrontier Corp
Report date November 10, 2021 · Filed November 10, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,588 |
Reported balance
After 2021-11-10 transaction · row 1
1 source rowRow 1 · 2021-11-10 · Grant · Acquired 4,180 · Balance 18,588 F1: Restricted stock units granted under the HollyFrontier Corporation 2020 Long Term Incentive Plan. The restricted stock units are subject to restrictions that will lapse on December 1, 2022, provided the reporting person has served on the board of directors of the Issuer from the grant date until such vesting date. Unless settlement is deferred pursuant to the company's deferred compensation arrangement for directors, the vested restricted stock units will be paid within 30 days following the vesting date in the form of the Issuer's common stock equal to the number of vested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units granted under the HollyFrontier Corporation 2020 Long Term Incentive Plan. The restricted stock units are subject to restrictions that will lapse on December 1, 2022, provided the reporting person has served on the board of directors of the Issuer from the grant date until such vesting date. Unless settlement is deferred pursuant to the company's deferred compensation arrangement for directors, the vested restricted stock units will be paid within 30 days following the vesting date in the form of the Issuer's common stock equal to the number of vested restricted stock units.
WILLIS TOWERS WATSON PLC
Report date May 11, 2022 · Filed May 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, nominal value $0.000304635 per shareSEC Table I · non-derivative | Direct | 5,975.7636 |
Reported balance
After 2022-05-11 transaction · row 1
1 source rowRow 1 · 2022-05-11 · Tax withholding · Disposed 291 · Balance 5,975.7636 F1: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 605 restricted share units granted on May 11, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 605 restricted share units granted on May 11, 2021.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Kraton Corp
Report date March 15, 2022 · Filed March 15, 2022
Section 16 reporting ended · disclosed 2022-03-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-03-15 transaction · row 1
1 source rowRow 1 · 2022-03-15 · Disposition to issuer · Disposed 40,331 · Balance 0 |
LANXESS Solutions US Inc.
Report date April 21, 2017 · Filed April 24, 2017
Section 16 reporting ended · disclosed 2017-04-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-04-21 transaction · row 1
1 source rowRow 1 · 2017-04-21 · Disposition to issuer · Disposed 26,794 · Balance 0 F1: On September 25, 2016, Chemtura Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lanxess Deutschland GmbH ("Lanxess") and LANXESS Solutions US Inc. (f/k/a LANXESS Additives Inc.) ("Merger Subsidiary"), pursuant to which Merger Subsidiary will merge (the "Merger") with and into the Company, whereupon the existence of Merger Subsidiary will cease and the Company will become the surviving corporation and a wholly-owned subsidiary of Lanxess. The Merger became effective on April 21, 2017 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Company's common stock, par value $0.01, outstanding immediately prior to the Effective Time was converted into the right to receive $33.50 in cash, without interest. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 25, 2016, Chemtura Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lanxess Deutschland GmbH ("Lanxess") and LANXESS Solutions US Inc. (f/k/a LANXESS Additives Inc.) ("Merger Subsidiary"), pursuant to which Merger Subsidiary will merge (the "Merger") with and into the Company, whereupon the existence of Merger Subsidiary will cease and the Company will become the surviving corporation and a wholly-owned subsidiary of Lanxess. The Merger became effective on April 21, 2017 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Company's common stock, par value $0.01, outstanding immediately prior to the Effective Time was converted into the right to receive $33.50 in cash, without interest.
Mead Johnson Nutrition Co
Report date June 15, 2017 · Filed June 15, 2017
Section 16 reporting ended · disclosed 2017-06-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 1
1 source rowRow 1 · 2017-06-15 · Disposition to issuer · Disposed 11,169 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-06-15 · Disposition to issuer · Disposed 1,709 · Balance 0 F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F3: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock.
F3: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2017 Filed Mar 2, 2017 10:08 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | GrantRestricted Stock Unit (RSU) · Derivative | 1,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016254 · doc4.xml · derivative · entry 2 Catalano Anna C · CIK 0001330575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,709 Underlying: Common Stock · 1,709 shares Expires 2018-02-28 F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock. F2 · price: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 09:27 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | SaleCommon Stock | 656 | $74.99 | $49,195.34 |
DisclosureSEC source: 0001209191-16-147556 · doc4.xml · nonDerivative · entry 1 Catalano Anna C · CIK 0001330575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,796 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.